Serum interleukin-5 levels correlate with disease activity of Churg-Strauss syndrome in a patient treated with a leucotriene receptor antagonist, pranlukast, and inhaled corticosteroid.
Scand J Rheumatol
; 39(4): 341-3, 2010 Aug.
Article
em En
| MEDLINE
| ID: mdl-20560805
ABSTRACT
This case report demonstrates that interleukin (IL)-5 levels and eosinophil cationic protein (ECP) correlated well with disease activity of Churg-Strauss syndrome (CSS) in a patient receiving treatment with leucotriene receptor antagonist and inhaled corticosteroid. In addition, ECP was localized in the inflamed tissue. IL-5 levels may thus provide a clue to therapeutic efficacy in patients with CSS using leucotriene receptor antagonists and inhaled corticosteroid.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Síndrome de Churg-Strauss
/
Cromonas
/
Interleucina-5
/
Androstadienos
Idioma:
En
Ano de publicação:
2010
Tipo de documento:
Article